NCT02553967 2026-03-17
REMASCO
Centre Oscar Lambret
Phase NA Completed
Clinical Trials
38 trialsNCT03258593 2026-03-17
Durvalumab and Vicineum in Subjects With High-Grade Non-Muscle-Invasive Bladder Cancer Previously Treated With Bacillus Calmette-Guerin (BCG)
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT07472868 2026-03-16
MEND-IT II
Catharina Ziekenhuis Eindhoven
Phase 3 Not yet recruiting
NCT02858310 2026-03-09
E7 TCR T Cells for Human Papillomavirus-Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT07458906 2026-03-09
DLL3-Targeted PET/CT in Neuroendocrine Carcinoma
The First Affiliated Hospital of Xiamen University
Phase NA Recruiting
NCT06819475 2026-03-06
Imaging Skeletal Muscle Mitochondrial OXPHOS Activity In Acute Lymphoblastic Leukemia Survivors
St. Jude Children's Research Hospital
Phase NA Recruiting
NCT04197297 2026-03-05
Brain Imaging Biomarkers in Patients With Brain Metastasis
University Health Network, Toronto
Phase 2 Recruiting
NCT05371054 2026-02-23
Study of VIP152, Venetoclax, and Prednisone (VVIP) in Relapsed/Refractory Lymphoid Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT05595577 2026-02-19
PALS
Wake Forest University Health Sciences
Phase NA Recruiting
NCT07416825 2026-02-18
Inter-Observer Delineation Differences in Esophageal Cancer GTV on MR, CT, and PET/CT Protokol šečerov Ermenc 28dec19
Institute of Oncology Ljubljana
Phase NA Completed
NCT04432597 2026-02-17
HPV Vaccine PRGN-2009 Alone or in Combination With Anti-PDL1/TGF-Beta Trap (M7824) in Subjects With HPV Associated Cancers
National Institutes of Health Clinical Center (CC)
Phase 1/2 Active not recruiting
NCT07277738 2026-02-04
PSID
Washington University School of Medicine
Phase NA Not yet recruiting
NCT04447027 2026-01-30
Romidepsin, CC-486 (5-azacitidine), Dexamethasone, and Lenalidomide (RAdR) for Relapsed/Refractory T-cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT07353229 2026-01-23
68Ga-Dotatate PET and MRI Guided Radiation Dose Escalation for High Risk Meningioma
Thomas Jefferson University
Phase 1 Suspended
NCT03234556 2025-12-22
Diagnosing Clinically Significant Prostate Cancer In African American and White Men With Elevated PSA
University of Southern California
Phase NA Active not recruiting
NCT06816979 2025-12-22
Lumbar Punctures for the Detection of ctDNA in the Cerebrospinal Fluid of Patients With Stage III and IV Non-Small Cell Lung Cancer
Ohio State University Comprehensive Cancer Center
Phase NA Not yet recruiting
NCT04369560 2025-12-17
Virtual Histology of the Bladder Wall for Bladder Cancer Staging
University of Pittsburgh
Phase EARLY_PHASE1 Recruiting
NCT05035407 2025-12-02
T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Terminated
NCT05975593 2025-11-12
METEOR-CRATR
Washington University School of Medicine
Phase NA Recruiting
NCT07223034 2025-11-04
A Study of 177Lu-PSMA-617 in People With Gliomas
Memorial Sloan Kettering Cancer Center
Phase 1 Recruiting
NCT06086704 2025-10-01
Study of 18F-FFNP Breast PET/MRI
University of Wisconsin, Madison
Phase 2 Recruiting
NCT02356159 2025-09-30
Study of Palifermin (Kepivance) in Persons Undergoing Unrelated Donor Allogeneic Hematopoietic Cell Transplantation
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT03493945 2025-09-30
Phase I/II Study of Immunotherapy Combination BN-Brachyury Vaccine, M7824, N-803 and Epacadostat (QuEST1)
National Institutes of Health Clinical Center (CC)
Phase 1/2 Completed
NCT00924027 2025-09-05
A Study of Patients Receiving High-Dose Rate Brachytherapy
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT05009979 2025-08-28
18F-DCFPyL PET/CT in Hepatocellular Carcinoma
National Institutes of Health Clinical Center (CC)
Phase 2 Terminated
NCT05334836 2025-08-11
FPPCN
Chinese University of Hong Kong
Phase NA Recruiting
NCT00923013 2025-08-08
Cladribine With Simultaneous or Delayed Rituximab to Treat Hairy Cell Leukemia
National Institutes of Health Clinical Center (CC)
Phase 2 Active not recruiting
NCT01879657 2025-08-06
68Ga-DOTATATE PET-CT for Diagnosis of Neuroendocrine Tumors (NETs)
Radio Isotope Therapy of America
Phase NA Completed
NCT03694938 2025-07-20
Detection of Brain Metastasis by MRI in Metastatic Colorectal Cancer Patients
Poitiers University Hospital
Phase NA Active not recruiting
NCT04227717 2025-07-18
Studying a New Piece of Equipment That Can Help Plan Radiation Therapy of the Spine
Memorial Sloan Kettering Cancer Center
Phase NA Completed
NCT06116253 2025-06-24
Advanced Diffusion Imaging in Renal Cancer Patients
NYU Langone Health
Phase NA Recruiting
NCT06629896 2025-06-24
CEM
Azienda USL Reggio Emilia - IRCCS
Phase NA Recruiting
NCT00001337 2025-06-22
Dose-Adjusted EPOCH Chemotherapy and Rituximab (CD20+) in Previously Untreated Aggressive Non-Hodgkin's Lymphoma
National Institutes of Health Clinical Center (CC)
Phase 2 Completed
NCT03448393 2025-06-04
CD19/CD22 Chimeric Antigen Receptor (CAR) T Cells in Children and Young Adults With Recurrent or Refractory CD19/CD22-expressing B Cell Malignancies
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT04875871 2025-05-11
PARTICLE-PATHY
EBG MedAustron GmbH
Phase NA Terminated
NCT05191940 2025-05-08
LAPC
EBG MedAustron GmbH
Phase NA Recruiting
NCT04685928 2025-05-06
SMART
Chinese University of Hong Kong
Phase NA Completed
NCT05298722 2025-04-02
PeRFormanCe
University Hospital, Ghent
Phase NA Recruiting